ScreenerHero

MVP Medical Developments International Limited

ASX · AU · Healthcare · Drug Manufacturers - General · medicaldev.com
—Mkt Cap: —P/E: —

Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manu…

Industry Peers

Drug Manufacturers - General
Screen all
LLY
Eli Lilly and Company
$1.12TUSDP/E 40.5
JNJ
Johnson & Johnson
$610.38BUSDP/E 28.7
ABBV
AbbVie Inc.
$500.80BUSDP/E 80.1
RO
Roche Holding AG
$370.64BUSDP/E 25.2
ROP
Roche Holding AG
$364.40BUSDP/E 24.8
MRK
Merck & Co., Inc.
$358.21BUSDP/E 115.2
ROG
Roche Holding AG
$340.19BUSDP/E 22.7
NOVN
Novartis AG
$288.24BUSDP/E 24.0
NVS
Novartis AG
$285.83BUSDP/E 22.0
AZN
AstraZeneca PLC
$260.71BUSDP/E 25.2
AZN
AstraZeneca PLC
$260.59BUSDP/E 26.7
AZN
AstraZeneca PLC
$258.50BUSDP/E 23.9
AMGN
Amgen Inc.
$234.65BUSDP/E 26.1
AZN
AstraZeneca PLC
$260.87BUSDP/E 25.4
GILD
Gilead Sciences, Inc.
$195.13BUSD
NOVO-B
Novo Nordisk A/S
$174.33BUSDP/E 10.1
NVO
Novo Nordisk A/S
$173.08BUSDP/E 9.6
PFE
Pfizer Inc.
$167.80BUSDP/E 38.7
BMY
Bristol-Myers Squibb Company
$123.73BUSDP/E 12.8
GSK
GSK plc
$98.21BUSDP/E 14.9

Key Statistics

Company
Market Cap—
Enterprise Value17.92M USD
Revenue (TTM)29.42M USD
Gross Profit21.20M USD
Net Income (TTM)432.62K USD
Revenue/Share0.38 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryDrug Manufacturers - General
ISINAU000000MVP2
Valuation
P/E (Trailing)—
P/E (Forward)10.84
PEG—
EV/EBITDA6.55
EV/Revenue0.61
P/S1.09
P/B0.83
EPS (TTM)0.01
EPS (Forward)0.04
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin72.05%
Oper. Margin8.11%
EBITDA Margin9.30%
Profit Margin1.47%
ROE1.13%
ROA2.28%
Growth
Revenue Growth10.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.97M USD
CapEx (TTM)718.73K USD
FCF Margin13.83%
FCF Yield—
Net Debt-13.62M USD
Net Debt/EBITDA-4.98
Balance Sheet
Debt/Equity0.04
Current Ratio5.77
Quick Ratio4.55
Book Value/Sh0.49 AUD
Cash/Share0.19 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield0.60%
Payout Ratio0.00%
Ex-Div DateMar 5, 2020
Pay Date—
Analyst Consensus
Rating—
Target (Mean)2.300 AUD
Target Range1.000 AUD – 3.600 AUD
# Analysts2
Ownership
Shares Out.112.66M
Float76.67M
Insiders23.92%
Institutions24.01%
Technical
SMA 500.4629 AUD
SMA 2000.4410 AUD
Beta1.56
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)126.98K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—